Shopping Cart
×

Aisling Capital

Aisling Capital

  • New York, New York, United States

  • New York, New York

Stage

  • Debt, Early Stage,Late Stage,Private Equity, Pos-Ipo

Type

  • Venture Capital

Description

Aisling Capital anticipates a healthcare revolution in the next decade driven by biotechnology advancements, particularly following the human genome project’s completion. These developments have spurred demand for capital to advance new therapeutics. Aisling Capital aims to support leading global healthcare companies in commercializing innovative healthcare products stemming from these breakthroughs.

Mission

Our goal is to support the leading global healthcare companies that are building on these technical and medical breakthroughs to commercialize new healthcare products.

Beauty Investments #

  • 1

Primary Sector

  • Biotechnology,Health Care, Medical

Beauty Exits #

  • 0

Last Beauty Invest

  • Jul, 2013-Tria Beauty

BEAUTY PORTFOLIO

How to Apply?

Submit your Pitch Here:https://www.aislingcapital.com/contact/ jhoerrner@aislingcapital.com

Criteria

OUR STRATEGY
Aisling Capital seeks to identify differentiated healthcare products, services and technologies that address unmet medical needs. Our business is to provide promising companies with meaningful capital resources and to assist them in achieving their growth objectives. We identify healthcare companies at a stage in their development where an infusion of capital and strategic assistance will significantly enhance the opportunities for success.
OUR INVESTMENT
Aisling Capital makes investment decisions driven by fundamental assessment of scientific, regulatory, financial and commercial risks. Given our investment team’s broad skillset, we invest across the life sciences, including seed and venture financings of development-stage companies, small-cap publicly traded equities, structured debt and royalty deals and large-cap leveraged buyouts of profitable companies.

Resources Breakdown Funding Terms
  • $4.6M To $40M

  • N/A

Education
  • TBD
Accelerator
  • Type-TBD
  • Duration-TBD
Network
  • 119
1:1
  • Yes

IMPERATIVE: CULTURE & VALUES

TBD

TBD

TBD

TBD

TBD

TBD

BEAUTY FUNDER FIT SCORE

Resources

Education

Accelerator

Network

1:1

2.65/10

*This score calculates the likelihood of any beauty brand getting funded by the investor. The score gives weights to number of beauty investments, recency of beauty investment, number of beauty exits, inclusivity inclination, resources offered, etc.

Inclusivity Investments %
  • 13.45%
Beauty Investments #
  • 1

Beauty Exits #
  • 0
Last Beauty Invest
  • Jul, 2013-Tria Beauty

LEAD DETAILS

Lead Contact

Dennis Purcell

Title

Founder and Senior Advisor

LinkedIn

Twitter Handle

Aisling Capital

Contact

jhoerrner@aislingcapital.com

1(212)651-6379

JUMP CONCLUSION

Aisling Capital strategically invests in biotechnology and healthcare companies globally, focusing on new therapeutics in sectors like oncology and precision medicine. With a strong presence in U.S. biotech hubs like California and Massachusetts, as well as international interests in the UK and Switzerland, they adopt a collaborative funding approach without necessarily leading investments, aiming to advance transformative healthcare innovations.

Casual Beauty Funder Fit. Tech-driven beauty & wellness brands targeting personal hygiene and wellness can still pitch.

Layer 1